WO2020135423A1 - 生物涂层和植入物 - Google Patents
生物涂层和植入物 Download PDFInfo
- Publication number
- WO2020135423A1 WO2020135423A1 PCT/CN2019/127936 CN2019127936W WO2020135423A1 WO 2020135423 A1 WO2020135423 A1 WO 2020135423A1 CN 2019127936 W CN2019127936 W CN 2019127936W WO 2020135423 A1 WO2020135423 A1 WO 2020135423A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coating
- layer
- bio
- surface layer
- biological coating
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30907—Nets or sleeves applied to surface of prostheses or in cement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2/30942—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/30769—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth madreporic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/3092—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having an open-celled or open-pored structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/3093—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth for promoting ingrowth of bone tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/30971—Laminates, i.e. layered products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/30985—Designing or manufacturing processes using three dimensional printing [3DP]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/08—Coatings comprising two or more layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Definitions
- the invention relates to the technical field of medical devices, in particular to a biological coating and an implant.
- the bio-coating of traditional implants is often produced by processes such as titanium bead sintering, plasma spraying, and diamond sandblasting. These processes make it difficult to change the porosity of the biocoating in a controlled manner, and it is difficult to ensure the connectivity of the pores and easily cause stress shielding. Further, adhesives are often used to connect the bio-coating layers and between the bio-coating layer and the substrate, and the connection stability is poor, thus affecting the bone ingrowth effect and the mechanical properties of the bio-coating and the implant. In addition, these processes are relatively complex, with long production cycles and high costs.
- a 3D printed gradient aperture porous metal bone tissue scaffold is disclosed.
- the bracket has a hexahedral structure, which is composed of components A, B, and C closely arranged, wherein component A is arranged in a matrix on the outermost layer of the hexahedral structure, component B is arrayed on the middle layer of the hexahedral structure, and component C is arrayed on The innermost layer of the hexahedral structure.
- the aperture of component A is larger than that of component B, and the aperture of component B is larger than the aperture of component C.
- the bracket structure is still relatively simple, because the components A, B, and C are all hexahedral structures, and the arrangement of the components A, B, and C in the bracket are all regular and orderly. Since the trabecular bone has an irregular porous network structure connecting pores, the scaffold structure is far away from the trabecular bone structure, so the long-term stability is poor and the effect of bone ingrowth is limited.
- the purpose of the present invention is to provide a biological coating and an implant to solve the problems of poor long-term stability and limited bone ingrowth effect of existing biological coatings and implants.
- the present invention provides a biological coating, including a surface layer, the surface layer includes a plurality of first monomers connected in a disordered manner, and between the plurality of first monomers and A plurality of first through holes are formed inside the plurality of first cells.
- the biological coating further includes at least one intermediate layer, the surface layer is disposed at the outermost side of the biological coating, and the surface layer and the at least one intermediate layer extend from the biological coating
- the direction from the outer side of the layer to the inner side of the bio-coating layer is sequentially arranged, and the porosity of the bio-coating layer gradually decreases from the outer side of the bio-coating layer to the inner side of the bio-coating layer.
- the porosity of the bio-coating gradually decreases from the outer side of the bio-coating to the inner side of the bio-coating.
- the porosity of the intermediate layer and the surface layer may be uniform in each layer Unchanged and gradually decreasing in the direction from the outside to the inside of the biological coating in different layers; it may also be that the porosities of the intermediate layer and the surface layer follow the The direction from the outer side to the inner side of the bio-coating gradually becomes smaller, and gradually decreases in the direction from the outer side to the inner side of the bio-coating between different layers; it may also be that the porosity in the entire bio-coating Continuous gradient change from the outside of the biological coating to the inside of the biological coating.
- the intermediate layer includes a plurality of second cells connected in a regular manner, and a plurality of second through holes are formed between the plurality of second cells and inside the plurality of second cells.
- the intermediate layer includes a plurality of second cells connected in a disordered manner, and a plurality of second through holes are formed between the plurality of second cells and inside the plurality of second cells .
- the structure of the first monomer in the surface layer and the second monomer in the intermediate layer are different.
- the first monomer has an N-hedron structure, the N ⁇ 10, the second monomer has an M-hedron structure, and the M ⁇ 10.
- the first monomer has one of a diamond dodecahedron structure, an icosahedral structure, and a dodecahedron structure
- the second monomer has a diamond structure, a honeycomb structure, a tetrahedral structure, or a cube One of structure, octahedral structure.
- the second monomer has a diamond structure, and the diamond structure is formed by four second connecting rods connected to each other, wherein one end of the four second connecting rods are connected to each other, and four The other ends of the second connecting rods are separated from each other, one end of the four second connecting rods connected to each other is located at the center point of the regular tetrahedron, and the other ends of the four second connecting rods are respectively located at the positive The four vertices of the tetrahedron.
- the number of the at least one intermediate layer is at least two, and there are multiple types of the second monomer.
- the first monomer is formed by connecting a plurality of first connecting rods
- the second monomer is formed by connecting a plurality of second connecting rods
- the rod diameter of the first connecting rod may be smaller
- the rod diameter of the second connecting rod is small, and the rod diameter of the first connecting rod in the surface layer is equal, and the rod diameter of the second connecting rod in the intermediate layer is equal, and/or
- the arrangement of the first connecting rods in the surface layer may be looser than the arrangement of the second connecting rods in the intermediate layer, and the arrangement of the first connecting rods in the surface layer is equal and dense
- the arrangement of the second connecting rods in the intermediate layer is equal in density; or, the rod diameter of the first connecting rod in the surface layer extends from the outside of the biological coating to the The direction of the inner side gradually becomes larger, and the rod diameter of the second connecting rod in the intermediate layer gradually becomes larger from the outer side of the biological coating to the inner side of the biological coating, in the surface layer
- the rod diameter of the first connecting rod is smaller than the rod diameter of
- the present invention also provides an implant including a base layer and the above-mentioned bio-coating layer, the bio-coating layer is disposed on the base layer, and the surface layer of the bio-coating layer is disposed on the outermost side of the implant .
- the surface layer is provided on the outermost side of the biological coating, the surface layer includes a plurality of first monomers connected in a disordered manner, between the plurality of first monomers, and a plurality of the A plurality of first through holes are formed inside the first cell. That is, since the plurality of first monomers in the surface layer are connected in a disordered manner, the plurality of first through holes in the surface layer may be in a disordered state, thereby facilitating the growth of corresponding bone tissue cells into the surface layer To further improve bone ingrowth effect and long-term stability.
- the biological coating further includes at least one intermediate layer, and the surface layer and the at least one intermediate layer are sequentially arranged along the direction from the outside of the biological coating to the inside of the biological coating, the The porosity of the biocoat gradually decreases in the direction from the outside of the biocoat to the inside of the biocoat.
- the surface layer of the bio-coating layer can have a good bone growth effect and long-term stability
- the intermediate layer of the bio-coating layer can have good mechanical properties
- the overall stability of the bio-coating layer is good.
- the plurality of second monomers in the intermediate layer are connected in a regular manner, the plurality of second through holes in the intermediate layer may be in an ordered state, so that the intermediate layer and all The bio-coating has good mechanical properties.
- the first through-hole in the first monomer connected in the disordered manner and the second connected in the disordered manner The structure of the second through hole in the monomer is very close to the natural three-dimensional structure and physiology of real cancellous bone, which can further improve the microstructure and biomechanical properties of the biological coating.
- the porosity and mechanical properties in the surface layer and the intermediate layer are also different.
- This embodiment can avoid the problem that the connecting rod is easily broken due to too small rod diameter and poor arrangement.
- this embodiment can also avoid the problem that the powder is difficult to remove due to the large diameter of the connecting rod and the dense arrangement.
- the porosity of the intermediate layer and the surface layer changes continuously along the direction from the outer side of the bio-coating layer to the inner side of the bio-coating layer, it is not easy to appear obvious Such as porosity, rod diameter, sparse arrangement, etc.) faults caused by discontinuities.
- the mechanical properties of the intermediate layer are better, the bone ingrowth effect of the surface layer is better, and the biological coating has better stability due to the better transition between the intermediate layer and the surface layer.
- FIG. 1 is a schematic structural diagram of a biological coating in Example 1 of the present invention.
- FIG. 2 is a partially enlarged schematic view of the biological coating in FIG. 1;
- FIG. 3 is a schematic diagram of the structure of the rhombic dodecahedron in the first embodiment of the present invention.
- Example 4 is a schematic diagram of the change of the porosity of the bio-coating in Example 1 of the present invention.
- FIG. 5 is a schematic diagram of the change of the porosity of the biological coating in an embodiment of the present invention.
- FIG. 6 is a schematic diagram of the change of the porosity of the biological coating in still another embodiment of the present invention.
- FIG. 7 is a schematic structural view of an implant in Embodiment 1 of the present invention.
- Example 8 is a schematic structural diagram of a biological coating in Example 2 of the present invention.
- FIG. 9 is a partially enlarged schematic view of the biological coating in FIG. 8.
- Example 10 is a schematic structural view of an implant in Example 2 of the present invention.
- Example 11 is a schematic structural view of a biological coating in Example 3 of the present invention.
- FIG. 12 is a partially enlarged schematic view of the biological coating in FIG. 11;
- FIG. 13 is a schematic structural view of a diamond structure in Embodiment 3 of the present invention.
- Example 14 is a schematic structural view of an implant in Example 3 of the present invention.
- Example 15 is a schematic structural view of a biological coating in Example 4 of the present invention.
- FIG. 16 is a partially enlarged schematic view of the biological coating in FIG. 15;
- Example 17 is a schematic structural view of an implant in Example 4 of the present invention.
- Example 18 is a schematic structural view of a biological coating in Example 5 of the present invention.
- FIG. 19 is a partially enlarged schematic view of the biological coating in FIG. 18;
- Example 5 is a schematic structural view of an implant in Example 5 of the present invention.
- FIG. 21 is a schematic diagram of the structure of an icosahedron in Embodiment 6 of the present invention.
- the present invention provides a biological coating, the biological coating includes a surface layer, the surface layer includes a plurality of monomers connected in a disordered manner, between the plurality of monomers and within the monomers Multiple through holes are formed. Because multiple monomers in the surface layer are connected in a disordered manner, multiple through holes in the surface layer can be in a disordered state, which can facilitate the growth of corresponding bone tissue cells into the surface layer, thereby improving bone growth Effect and long-term stability.
- the present invention also provides an implant including a base layer and a biological coating layer disposed on the base layer. Since the plurality of through holes in the surface layer of the biological coating layer can be in a disordered state, the bone ingrowth effect and long-term stability of the implant can be improved.
- FIG. 1 is a schematic structural diagram of a bio-coating 100 in Embodiment 1 of the present invention
- FIG. 2 is a partially enlarged schematic view of part A of the bio-coating 100 in FIG. 1.
- the biological coating 100 includes a surface layer 110 and an intermediate layer 120.
- the surface layer 110 is disposed on the intermediate layer 120.
- the surface layer 110 is disposed on the outermost layer of the biological coating 100.
- the porosity of the surface layer 110 is greater than the porosity of the intermediate layer 120.
- the surface layer 110 includes a plurality of first monomers connected in a disordered manner.
- a plurality of first through holes are formed between the plurality of first cells and inside the first cell.
- FIG. 3 is a schematic structural diagram of a rhombic dodecahedron in Embodiment 1 of the present invention.
- the first unit is a diamond-shaped dodecahedron connected by a plurality of first connecting rods 140, so a plurality of first through holes are formed inside.
- the first through hole may be formed by connecting two adjacent first cells to each other.
- the plurality of first monomers in the surface layer 110 are connected in a disordered manner, the plurality of first through holes in the surface layer 110 may be in a disordered state, thereby facilitating the growth of corresponding bone tissue cells into the surface In layer 110, the bone ingrowth effect and long-term stability are further improved.
- the pore diameter of the first through hole is 100-1000 ⁇ m, and the porosity of the surface layer 110 is 50-80%.
- the biological coating 100 can have better bone ingrowth effect and long-term stability, and at the same time, the surface layer 110 can have a higher roughness and friction coefficient, and the biological coating 100 can have a good short-term stability.
- the intermediate layer 120 includes a plurality of second cells connected in a regular manner, and a plurality of second through holes are formed between the plurality of second cells and inside the plurality of second cells.
- the second unit is a rhombic dodecahedron connected by a plurality of second connecting rods, so a plurality of second through holes are formed inside.
- the second through hole may be formed by connecting two adjacent second monomers to each other.
- the plurality of second monomers in the intermediate layer 120 are connected in a regular manner, the plurality of second through holes in the intermediate layer 120 may be in an ordered state, so that the intermediate layer 120 and the organism The coating 100 has better mechanical properties.
- the pore diameter of the second through hole is 100 ⁇ m-1000 ⁇ m, and the porosity of the intermediate layer 120 is 10-60%.
- the total thickness of the bio-coating 100 is 0.5-5.0 mm, and the bio-coating 100 has a high porosity.
- the biological coating 100 can be designed by computer software and integrally formed by 3D printing. In this way, the porosity of the surface layer 110 and the intermediate layer 120 can be changed in a controllable manner, so that between the plurality of first through holes and the plurality of second through holes in the biological coating 100 The connectivity between and between the plurality of first through holes and the plurality of second through holes is good.
- FIG. 4 is a schematic diagram of the change of the porosity of the bio-coating 100 in Embodiment 1 of the present invention.
- the porosity of the intermediate layer 120 is less than the porosity of the surface layer 110, and the porosity in the intermediate layer 120 and the surface layer 110 is uniform, that is, the porosity is only between the intermediate layer 120 and the surface layer 110 Changes between.
- the porosity of the surface layer 110 is relatively large, which can provide sufficient growth space for tissue cells, which is beneficial to the transportation of nutrients and the discharge of metabolic waste, thereby having a better bone growth effect.
- the porosity of the intermediate layer 120 is relatively small, which can provide better mechanical properties.
- the porosity can be changed by the change in the rod diameter of the first connecting rod 140 and the second connecting rod and/or the change in the arrangement of the density.
- the rod diameter of the first connecting rod 140 is smaller than the rod diameter of the second connecting rod, and the rod diameter of the first connecting rod 140 in the surface layer 110 is the same, and the intermediate layer 120
- the rod diameters of the second connecting rods are equal, and/or the arrangement of the first connecting rods 140 in the surface layer 110 may be looser than the arrangement of the second connecting rods in the middle layer 120, and the The arrangement of the first connecting rods 140 in the surface layer 110 is equal in density, and the arrangement of the second connecting rods in the intermediate layer 120 is equal in density.
- the change of the porosity of the bio-coating layer 100 may be different from this embodiment.
- FIG. 5 is a schematic diagram of changes in the porosity of the bio-coating 100 in an embodiment of the present invention.
- the porosity of the intermediate layer 120 is smaller than the porosity of the surface layer 110, and the porosity in the intermediate layer 120 and the surface layer 110 gradually decreases from the outside to the inside in each layer, wherein, the The side of the surface layer 110 far away from the middle layer 120 is the outside of the biological coating 100, and the side of the middle layer 120 far away from the surface layer 110 is the inside of the biological coating 100.
- the porosity of the surface layer 110 is relatively large, which can provide sufficient growth space for tissue cells, which is beneficial to the transportation of nutrients and the discharge of metabolic waste, thereby having a better bone growth effect.
- the porosity of the intermediate layer 120 is relatively small, which can provide better mechanical properties.
- the rod diameter of the first connecting rod 140 in the surface layer 110 gradually increases from the outside of the biological coating 100 to the inside of the biological coating 100, and the rod of the second connecting rod in the intermediate layer 120 The diameter gradually increases in the direction from the outside of the bio-coating 100 to the inside of the bio-coating 100, and the overall diameter of the first connecting rod 140 in the surface layer 110 is larger than that of the second connection in the intermediate layer 120
- the rod diameter of the rod is small; and/or the arrangement of the first connecting rods 140 in the surface layer 110 gradually becomes denser from the outer side of the biological coating 100 to the inner side of the biological coating 100, the intermediate layer 120
- the arrangement of the second connecting rods gradually becomes denser in the direction from the outer side of the biological coating 100 to the inner side of the biological coating 100, and the overall arrangement of the first connecting rods 140 in the surface layer 110 is lower than that of the middle
- the arrangement of the second connecting rods in layer 120 is
- FIG. 6 is a schematic diagram of changes in the porosity of the bio-coating 100 in still another embodiment of the present invention.
- the porosity of the intermediate layer 120 is smaller than the porosity of the surface layer 110, and the porosity of the bio-coating layer 100 gradually decreases from the outside to the inside.
- the porosity in the bio-coating 100 changes continuously in the direction from outside to inside. Continuous gradient change means that the porosity changes linearly.
- the layer-to-layer junction is prone to fracture due to stress concentration, and continuous gradient changes will not cause obvious stress concentration. Lead to faults.
- the mechanical properties of the intermediate layer 120 are better and the bone ingrowth effect of the surface layer 110 is better.
- the biological coating 100 can have better stability.
- the rod diameters of the first connecting rod 140 and the second connecting rod in the biological coating 100 gradually become larger in the direction from the outside of the biological coating 100 to the inside of the biological coating 100, and/or The arrangement of the first connecting rod 140 and the second connecting rod in the biological coating 100 gradually becomes denser from the outside of the biological coating 100 to the inside of the biological coating 100.
- the number of the intermediate layers 120 is at least two.
- the surface layer 110 and the plurality of intermediate layers 120 are sequentially arranged from the outside of the bio-coating 100 to the inside of the bio-coating 100.
- the porosity between the layers in the bio-coating layer 100 gradually decreases from the outside to the inside, and the porosity in each of the intermediate layer 120 and the surface layer 110 is uniform.
- the porosity of each of the one or more intermediate layers 120 gradually decreases from outside to inside, and/or the porosity of the surface layer 110 extends from outside to inside The direction gradually becomes smaller.
- the porosity of each of the plurality of intermediate layers 120 is less than the porosity of the surface layer 110, and the porosity of the bio-coating layer 100 gradually decreases from the outside to the inside.
- the biological coating 100 has a bone-like trabecular structure.
- FIG. 7 is a schematic structural diagram of an implant in Embodiment 1 of the present invention.
- the implant includes a base layer 200 and the bio-coating 100 in the first embodiment above, wherein the intermediate layer 120 in the bio-coating is disposed on the base layer 200, and the surface in the bio-coating Layer 110 is provided on the outermost side of the implant.
- the base layer 200 may also be a porous coating layer, and the porosity of the base layer 200 is smaller than the porosity of the intermediate layer 120.
- the base layer 200 may be integrally formed by 3D printing.
- the whole implant can be integrally formed by 3D printing.
- This embodiment provides a biological coating 100.
- the difference between the bio-coating 100 in this embodiment and the bio-coating 100 in Embodiment 1 is that the plurality of second monomers in the intermediate layer 120 are connected in a disordered manner.
- FIG. 8 is a schematic structural diagram of a bio-coating 100 in Embodiment 2 of the present invention
- FIG. 9 is a partially enlarged schematic view of part B of the bio-coating 100 in FIG. 8.
- the biological coating 100 includes a surface layer 110 and an intermediate layer 120.
- the surface layer 110 is disposed on the intermediate layer 120, and the surface layer 110 is disposed on the outermost side of the biological coating 100.
- the porosity of the surface layer 110 is greater than the porosity of the intermediate layer 120, and the intermediate layer 120 includes a plurality of second monomers connected in a disordered manner.
- the connectivity between the plurality of first through-holes, between the plurality of second through-holes, and between the plurality of first through-holes and the plurality of second through-holes in the biocoating 100 affects the blood vessels in the biocoating 100 It has an effect, that is, low connectivity is easy to cause the new bone to be unable to connect with each other, which makes the integration and continuity of the new bone insufficient.
- the plurality of second monomers in the intermediate layer 120 are connected in a regular manner, which can ensure that the biological coating has good porosity and connectivity, the structure of the biological coating and the structure of real cancellous bone have Large gap.
- the structure of natural cancellous bone is complex, its pore size is normally distributed, and pores with different pore sizes have different biological functions.
- the structure of the first through hole in the first monomer connected in a disordered manner and the second through hole in the second monomer connected in a disordered manner is very similar to the natural three-dimensional structure and physiology of real cancellous bone It is close, so the microstructure and biomechanical properties of the bio-coating 100 can be further improved.
- the porosity can be changed by the change in the rod diameter of the first connecting rod 140 and the second connecting rod and/or the change in the arrangement of the density.
- the porosity of the intermediate layer 120 and the surface layer 110 may be uniform within each layer and vary from layer to layer, or may gradually decrease in the direction from outside to inside within each layer, or The entire biological coating 100 gradually becomes smaller from the outside to the inside.
- FIG. 10 is a schematic structural diagram of an implant in Embodiment 2 of the present invention.
- the implant includes a base layer 200 and the bio-coating 100 in the second embodiment above, wherein the intermediate layer 120 in the bio-coating is disposed on the base layer 200, and the surface in the bio-coating Layer 110 is provided on the outermost side of the implant.
- the base layer 200 may also be a porous coating layer, and the porosity of the base layer 200 is smaller than the porosity of the intermediate layer 120.
- the base layer 200 may be integrally formed by 3D printing.
- the whole implant can be integrally formed by 3D printing.
- This embodiment provides a biological coating 100.
- the difference between the bio-coating 100 in this embodiment and the bio-coating 100 in Embodiment 1 is that the second monomer has a diamond structure.
- FIG. 11 is a schematic structural diagram of a bio-coating 100 in Embodiment 3 of the present invention
- FIG. 12 is a partially enlarged schematic view of part C of the bio-coating 100 in FIG. 11.
- the biological coating 100 includes a surface layer 110 and an intermediate layer 120.
- the surface layer 110 is disposed on the intermediate layer 120, and the surface layer 110 is disposed on the outermost side of the biological coating 100.
- the porosity of the surface layer 110 is greater than the porosity of the intermediate layer 120, and the intermediate layer 120 includes a plurality of second monomers connected in a regular manner.
- the second monomer has a diamond structure connected by a plurality of second connecting rods.
- FIG. 13 is a schematic structural diagram of a diamond structure in Embodiment 3 of the present invention.
- the diamond structure is formed by four second connecting rods 150 connected to each other. One end of the four second connecting rods 150 is connected to each other, and the other ends of the four second connecting rods 150 are separated from each other. One end of the four second connecting rods 150 connected to each other is located at the center point of the regular tetrahedron, and the other ends of the four second connecting rods 150 are respectively located at the four vertices of the regular tetrahedron.
- the first monomer in the surface layer 110 has a diamond dodecahedron structure
- the second monomer in the intermediate layer 120 has a diamond structure. Therefore, the monomer structures in the surface layer 110 and the intermediate layer 120 are different, so that the porosity and mechanical properties of the surface layer 110 and the intermediate layer 120 can also be changed.
- the bio-coating 100 in this embodiment can be avoided The problem that the first connecting rod 140 and the second connecting rod 150 are easily broken due to the excessively small rod diameter and the poor arrangement.
- the bio-coating 100 in this embodiment can also avoid the problem that the powder is difficult to remove due to the excessively large rod diameter and the dense arrangement.
- the porosity may be further changed by changing the rod diameter of the first connecting rod 140 and the second connecting rod 150 and/or by changing the density and density.
- This embodiment can be combined with the use of different monomers in the surface layer 110 and the intermediate layer 120 to affect the porosity and the changes in the rod diameter and/or density arrangement of the first connecting rod 140 and the second connecting rod 150.
- the porosity has an effect, so that the advantages of the two ways of adjusting the porosity can be combined, so that the stability of the biological coating 100 and the effect of bone ingrowth are better.
- the porosity of the intermediate layer 120 and the surface layer 110 may be uniform in each layer and only change from layer to layer, or may gradually decrease in the direction from outside to inside in each layer Alternatively, the entire biological coating 100 may gradually become smaller from the outside to the inside.
- FIG. 14 is a schematic structural diagram of an implant in Embodiment 3 of the present invention.
- the implant includes a base layer 200 and the bio-coating 100 in Embodiment 3 above, wherein the intermediate layer 120 in the bio-coating is disposed on the base layer 200, and the bio-coating
- the surface layer 110 is disposed on the outermost side of the biological coating 100.
- the base layer 200 may also be a porous coating layer, and the porosity of the base layer 200 is smaller than the porosity of the intermediate layer 120.
- the base layer 200 may be integrally formed by 3D printing.
- the whole implant can be integrally formed by 3D printing.
- This embodiment provides a biological coating 100.
- the difference between the bio-coating 100 in this embodiment and the bio-coating 100 in Embodiment 1 is that a plurality of second monomers in the intermediate layer 120 are connected in a disordered manner, and the second monomers have diamonds structure.
- FIG. 15 is a schematic structural diagram of a bio-coating 100 in Embodiment 4 of the present invention
- FIG. 16 is a partially enlarged schematic view of part D of the bio-coating 100 in FIG.
- the biological coating 100 includes a surface layer 110 and an intermediate layer 120.
- the surface layer 110 is disposed on the intermediate layer 120, and the surface layer 110 is disposed on the outermost side of the biological coating 100.
- the porosity of the surface layer 110 is greater than the porosity of the intermediate layer 120, and the intermediate layer 120 includes a plurality of second monomers connected in a disordered manner.
- the second monomer has a diamond structure connected by a plurality of second connecting rods.
- the diamond structure is formed by four second connecting rods connected to each other. Wherein, one end of the four second connecting rods is connected to each other, and the other ends of the four second connecting rods are separated from each other. One end of the four connecting rods connected to each other is located at the center point of the tetrahedron, and the other ends of the four second connecting rods are located at the four vertices of the tetrahedron, respectively.
- the first monomer in the surface layer 110 has a diamond dodecahedron structure
- the second monomer in the intermediate layer 120 has a diamond structure. Therefore, the monomer structures in the surface layer 110 and the intermediate layer 120 are different, so that the porosity and mechanical properties of the surface layer 110 and the intermediate layer 120 can also be changed.
- the bio-coating 100 in this embodiment can be avoided The problem that the diameter of the rod is too small and the first connecting rod 140 and the second connecting rod are easily broken due to the sparse arrangement.
- the bio-coating 100 in this embodiment can also avoid the problem that the powder is difficult to remove due to the excessively large rod diameter and the dense arrangement.
- the porosity may be further changed by changing the diameters of the first connecting rod 140 and the second connecting rod and/or by changing the density and density.
- This embodiment can combine the manner in which the porosity is affected by using different monomers in the surface layer 110 and the intermediate layer 120 and the change in the rod diameter and/or the density arrangement through the first connecting rod 140 and the second connecting rod.
- the way of influencing the porosity can combine the advantages of these two ways of adjusting the porosity, so that the stability of the biological coating 100 and the effect of bone ingrowth are better.
- the structure of natural cancellous bone is complex, the pore size is normally distributed, and pores with different pore sizes have different biological functions. Therefore, the structure of the first through hole in the first monomer connected in a disordered manner and the second through hole in the second monomer connected in a disordered manner is different from the natural three-dimensional structure of the actual cancellous bone and The physiology is very close, so the microstructure and biomechanical properties of the bio-coating 100 can be further improved.
- the porosity of the intermediate layer 120 and the surface layer 110 may be uniform in each layer and vary from layer to layer, or may gradually decrease in the direction from the outside to the inside in each layer.
- FIG. 17 is a schematic structural diagram of an implant in Embodiment 4 of the present invention.
- the implant includes a base layer 200 and the bio-coating 100 in the fourth embodiment described above, the intermediate layer 120 in the bio-coating is disposed on the base layer 200, and the surface in the bio-coating Layer 110 is provided on the outermost side of the implant.
- the base layer 200 may also be a porous coating layer, and the porosity of the base layer 200 is smaller than the porosity of the intermediate layer 120.
- the base layer 200 may be integrally formed by 3D printing.
- the whole implant can be integrally formed by 3D printing.
- This embodiment provides a biological coating 100.
- the difference between the bio-coating 100 in this embodiment and the bio-coating 100 in Embodiment 1 is that a plurality of second monomers in the intermediate layer 120 are connected in a disordered manner, and the second monomers have The diamond structure and the overall porosity of the bio-coating 100 vary continuously from outside to inside.
- FIG. 18 is a schematic structural diagram of a bio-coating 100 in Embodiment 5 of the present invention
- FIG. 19 is a partially enlarged schematic view of part E of the bio-coating 100 in FIG. 18.
- the biological coating 100 includes a surface layer 110 and an intermediate layer 120.
- the surface layer 110 is disposed on the intermediate layer 120, and the surface layer 110 is disposed on the outermost side of the biological coating 100.
- the porosity of the surface layer 110 is greater than the porosity of the intermediate layer 120, and the intermediate layer 120 includes a plurality of second monomers connected in a disordered manner.
- the second monomer has a diamond structure connected by a plurality of second connecting rods.
- the diamond structure is formed by four second connecting rods connected to each other. Wherein, one end of the four second connecting rods is connected to each other, the other ends of the four second connecting rods are separated from each other, and one end of the four second connecting rods connected to each other is located in the center of the tetrahedron At the point, the other ends of the four second connecting rods are respectively located at the four vertices of the tetrahedron.
- the first monomer in the surface layer 110 has a diamond dodecahedron structure
- the second monomer in the intermediate layer 120 has a diamond structure. Therefore, the monomer structures in the surface layer 110 and the intermediate layer 120 are different, so that the porosity and mechanical properties of the surface layer 110 and the intermediate layer 120 can also be changed.
- the bio-coating 100 in this embodiment can be avoided The problem that the diameter of the rod is too small and the first connecting rod 140 and the second connecting rod are easily broken due to the sparse arrangement.
- the bio-coating 100 in this embodiment can also avoid the problem that the powder is difficult to remove due to the excessively large rod diameter and the dense arrangement.
- the porosity may be further changed by changing the diameters of the first connecting rod 140 and the second connecting rod and/or by changing the density and density.
- This embodiment can be combined with the way in which different monomers are used in the surface layer 110 and the intermediate layer 120 to affect the porosity and the change in the rod diameter and/or the density arrangement of the first connecting rod 140 and the second connecting rod.
- the way of affecting the porosity so that the advantages of the porosity can be adjusted by combining these two ways, so that the stability of the biological coating 100 and the effect of bone ingrowth are better.
- the structure of natural cancellous bone is complex, the pore size is normally distributed, and pores with different pore sizes have different biological functions. Therefore, the structure of the first through hole in the first monomer connected in a disordered manner and the second through hole in the second monomer connected in a disordered manner is different from the natural three-dimensional structure of the actual cancellous bone and The physiology is very close, so the microstructure and biomechanical properties of the bio-coating 100 can be further improved.
- the porosity of the intermediate layer 120 is smaller than the porosity of the surface layer 110, and the porosity of the bio-coating layer 100 gradually decreases from the outside to the inside. That is to say, the porosity in the intermediate layer 120 and the surface layer 110 changes continuously from the outside to the inside, and no obvious properties (such as porosity, rod diameter, sparse arrangement, etc.) will result in discontinuities caused by discontinuities.
- the mechanical properties of the intermediate layer 120 are better, the bone ingrowth effect of the surface layer 110 is better, and there is a better transition between the intermediate layer 120 and the surface layer 110, which can make the biological coating 100 have better stability.
- FIG. 20 is a schematic structural diagram of an implant in Embodiment 5 of the present invention.
- the implant includes a base layer 200 and the bio-coating 100 in Embodiment 5 above, wherein the intermediate layer 120 in the bio-coating is disposed on the base layer 200, and the bio-coating The surface layer 110 is provided on the outermost side of the implant.
- the base layer 200 may also be a porous coating layer, and the porosity of the base layer 200 is less than the porosity of the intermediate layer 120.
- the base layer 200 may be integrally formed by 3D printing.
- the whole implant can be integrally formed by 3D printing.
- the second monomer in the middle layer all has a diamond structure, wherein a plurality of the diamond structures in the third embodiment are connected in a regular manner.
- a plurality of the diamond structures are connected in a disordered manner.
- a diamond structure connected in a regular manner is formed by four interconnected second connecting rods, wherein one end of the four second connecting rods is connected to each other, and the other ends of the four second connecting rods are separated from each other
- One end of the four second connecting rods connected to each other is located at the center point of the regular tetrahedron, and the other ends of the four second connecting rods are respectively located at the four vertices of the regular tetrahedron.
- the angle between the second connecting rod and the second connecting rod has changed, and the length of the second connecting rod has also changed. That is to say, the diamond structure connected in a disordered manner actually has no regular tetrahedral structure but a deformed tetrahedral structure.
- the diamond structure is the optimal solution for the structure of the second monomer as the intermediate layer.
- the second monomer of the intermediate layer may also have other structures, which is not limited by the present invention.
- the biological coating 100 includes a surface layer 110 and an intermediate layer 120.
- the surface layer 110 is disposed on the intermediate layer 120.
- the surface layer 110 is disposed on the outermost side of the biological coating 100.
- the porosity of the surface layer 110 is greater than the porosity of the intermediate layer 120.
- the surface layer 110 includes a plurality of first cells connected in a disordered manner, and a plurality of first through holes are formed between the plurality of first cells and inside the first cells.
- the first monomer may have an N-hedron structure, and N ⁇ 10.
- the first monomer may have one of a rhombic dodecahedral structure, an icosahedral structure, and a dodecahedral structure (soccerene structure).
- the structure of the icosahedron can be referred to FIG. 21, which is a schematic diagram of the structure of the icosahedron in Embodiment 6 of the present invention.
- the intermediate layer 120 includes a plurality of second cells connected in a regular manner, and a plurality of second through holes are formed between the plurality of second cells and inside the second cell.
- the second monomer may have an M-hedron structure, and M ⁇ 10.
- the second monomer may have one of a tetrahedral structure, a cubic structure, and an octahedral structure.
- the second monomer may also have one of diamond structure or honeycomb structure.
- the second monomers can also be arranged in a disordered manner.
- the implant includes a base layer 200 and the bio-coating layer 100 in the sixth embodiment above, wherein the intermediate layer 120 in the bio-coating layer is disposed on the base layer 200, and the surface in the bio-coating layer Layer 110 is provided on the outermost side of the implant.
- the base layer 200 may also be a porous coating layer, and the porosity of the base layer 200 is smaller than the porosity of the intermediate layer 120.
- the base layer 200 may be integrally formed by 3D printing.
- the whole implant can be integrally formed by 3D printing.
- This embodiment provides a biological coating 100.
- the biological coating 100 includes only the surface layer 110.
- the surface layer 110 includes a plurality of first cells connected in a disordered manner, and a plurality of first through holes are formed between the plurality of first cells and inside the first cells.
- the first monomer may have a K-hedron structure, and K ⁇ 4.
- the first monomer may have one of a rhombic dodecahedral structure, an icosahedral structure, a dodecahedral structure (soccerene structure), a tetrahedral structure, a cubic structure, and an octahedral structure.
- the first monomer may also have one of a diamond structure or a honeycomb structure.
- the implant includes a base layer 200 and the bio-coating 100 in the seventh embodiment.
- the base layer 200 may also be a porous coating layer, and the porosity of the base layer 200 is less than the porosity of the surface layer 110.
- the base layer 200 may be integrally formed by 3D printing.
- the whole implant can be integrally formed by 3D printing.
- the surface layer 110 is disposed on the outermost side of the bio-coating layer 100.
- the surface layer 110 includes a plurality of first monomers connected in a disordered manner, and a plurality of the first monomers A plurality of first through holes are formed between the first cell and the first cell. That is, since the plurality of first monomers in the surface layer 110 are connected in a disordered manner, the plurality of first through holes in the surface layer 110 may be in a disordered state, thereby facilitating the growth of corresponding bone tissue cells into the surface In layer 110, the bone ingrowth effect and long-term stability are further improved.
- the biological coating 100 further includes at least one intermediate layer 120.
- the surface layer 110 and the at least one intermediate layer 120 extend from the outer side of the biological coating 100 to the biological coating 100.
- the direction of the inner side is sequentially set, and the porosity of the bio-coating layer 100 gradually decreases from the outside of the bio-coating layer 100 to the inside of the bio-coating layer 100.
- the surface layer 110 of the bio-coating 100 may have better bone ingrowth effect and long-term stability
- the intermediate layer 120 of the bio-coating 100 may have better short-term stability, the bio-coating 100 The overall stability is good.
- the plurality of second cells in the intermediate layer 120 are connected in a regular manner, the plurality of second through holes in the intermediate layer 120 may be in an ordered state, so that the intermediate layer 120 And the biological coating 100 has better mechanical properties.
- the first through hole in the first monomer connected in the disordered manner and the second monomer connected in the disordered manner The structure of the second through hole in the body is very close to the natural three-dimensional structure and physiology of the actual cancellous bone, so that the microstructure and biomechanical properties of the biocoating 100 can be further improved.
- the bio-coating in the above embodiment can avoid the problem that the first connecting rod 140 and the second connecting rod are easily broken due to the excessively small rod diameter and the excessive arrangement.
- the bio-coating in the above embodiment can also avoid the problem that the powders caused by the first connecting rod 140 and the second connecting rod are too large and the arrangement is too dense to remove the powder.
- the porosity of the intermediate layer 120 and the surface layer 110 changes continuously in the direction from the outside of the bio-coating 100 to the inside of the bio-coating 100, it is unlikely to appear obvious Of faults caused by discontinuities in properties (such as porosity, rod diameter, sparse arrangement, etc.).
- the mechanical properties of the intermediate layer 120 are better, the bone ingrowth effect of the surface layer 110 is better, and the bio-coating layer 100 can have better quality due to the better transition between the intermediate layer 120 and the surface layer 110 stability.
- the biological coating 100 may be integrally formed by 3D printing. In this way, the porosity of the surface layer 110 and the intermediate layer 120 can be changed in a controlled manner. Therefore, the connectivity between the plurality of first through holes, between the plurality of second through holes, and between the plurality of first through holes and the plurality of second through holes in the biological coating 100 is good.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Manufacturing & Machinery (AREA)
- Materials Engineering (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Geometry (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (14)
- 一种生物涂层,其特征在于,包括表面层,所述表面层包括多个以无序的方式连接的第一单体,多个所述第一单体之间以及多个所述第一单体的内部形成有多个第一通孔。
- 如权利要求1所述的生物涂层,其特征在于,还包括至少一层中间层,所述表面层设置于所述生物涂层的最外侧,所述表面层和所述至少一层中间层沿所述生物涂层的外侧到所述生物涂层的内侧的方向依次设置,所述生物涂层的孔隙率沿所述生物涂层的外侧到所述生物涂层的内侧的方向逐渐变小。
- 如权利要求2所述的生物涂层,其特征在于,所述至少一层中间层包括多个以规则方式连接的第二单体,多个所述第二单体之间以及多个所述第二单体的内部形成有多个第二通孔。
- 如权利要求2所述的生物涂层,其特征在于,所述至少一层中间层包括多个以无序方式连接的第二单体,多个所述第二单体之间以及多个所述第二单体的内部形成有多个第二通孔。
- 如权利要求3或4所述的生物涂层,其特征在于,所述表面层中的第一单体与所述至少一层中间层中的第二单体的结构不相同。
- 如权利要求5所述的生物涂层,其特征在于,所述第一单体具有N面体结构,所述N≥10,所述第二单体具有M面体结构,所述M<10。
- 如权利要求5所述的生物涂层,其特征在于,所述第一单体具有菱形十二面体结构、二十面体结构、三十二面体结构中的一种,所述第二单体具有钻石结构、蜂窝结构、四面体结构、立方体结构、八面体结构中的一种。
- 如权利要求5所述的生物涂层,其特征在于,所述第二单体具有钻石结构,所述钻石结构由四个相互连接的第二连接杆形成,其中,四个所述第二连接杆的一端相互连接在一起,四个所述第二连接杆的另一端相互分离,四个所述第二连接杆相互连接在一起的一端位于正四面体的中心点处,四个 所述第二连接杆的另一端分别位于所述正四面体的四个顶点上。
- 如权利要求3或4所述的生物涂层,其特征在于,所述至少一层中间层的数量为至少两个,所述第二单体的种类为多种。
- 如权利要求3或4所述的生物涂层,其特征在于,所述中间层和所述表面层的孔隙率,在各层内均一不变且在不同层中沿所述生物涂层的外侧到所述生物涂层的内侧的方向逐渐变小;或者,所述中间层和所述表面层的孔隙率,在各层内沿所述生物涂层的外侧到所述生物涂层的内侧的方向逐渐变小,在不同层中沿所述生物涂层的外侧到内侧的方向逐渐变小;或者,所述生物涂层的孔隙率从所述生物涂层的外侧到所述生物涂层的内侧连续梯度变化。
- 如权利要求3或4所述的生物涂层,其特征在于,所述第一单体由多个第一连接杆连接而成,所述第二单体由多个第二连接杆连接而成;所述第一连接杆的杆径较所述第二连接杆的杆径小,且所述表面层中的所述第一连接杆的杆径相等,所述中间层中的所述第二连接杆的杆径相等,和/或所述表面层中的所述第一连接杆的排列较所述中间层中的所述第二连接杆的排列疏,且所述表面层中的所述第一连接杆的排列疏密相等,所述中间层中的所述第二连接杆的排列疏密相等;或者,所述表面层中的所述第一连接杆的杆径沿所述生物涂层的外侧到所述生物涂层的内侧的方向逐渐变大,所述中间层中的所述第二连接杆的杆径沿所述生物涂层的外侧到所述生物涂层的内侧的方向逐渐变大,所述表面层中的所述第一连接杆的杆径整体较所述中间层中的所述第二连接杆的杆径小,和/或所述表面层中的所述第一连接杆的排列沿所述生物涂层的外侧到所述生物涂层的内侧的方向逐渐变密,所述中间层中的所述第二连接杆的排列沿所述生物涂层的外侧到所述生物涂层的内侧逐渐变密,所述表面层中的所述第一连接杆的排列整体较所述中间层中的所述第二连接杆的排列疏;或者,所述生物涂层中的所述第一连接杆和所述第二连接杆的杆径整体沿所述生物涂层的外侧到所述生物涂层的内侧的方向逐渐变大,和/或所述生物涂层中的所述第一连接杆和所述第二连接杆的排列整体沿所述生物涂层的外侧到 所述生物涂层的内侧的方向逐渐变密。
- 如权利要求1-11中任何一项所述的生物涂层,其特征在于,采用计算机软件设计并通过3D打印的方式一体成型。
- 一种植入物,其特征在于,包括基底层以及如权利要求1至11任一项所述的生物涂层,所述生物涂层设置在所述基底层上,所述生物涂层的表面层设置在所述植入物的最外侧。
- 如权利要求13所述的植入物,其特征在于,所述植入物整体通过3D打印的方式一体成型。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/418,155 US20220054716A1 (en) | 2018-12-29 | 2019-12-24 | Bio-coating and implant |
KR1020217020339A KR20210096653A (ko) | 2018-12-29 | 2019-12-24 | 바이오 코팅 및 임플란트 |
EP19905352.1A EP3903741B1 (en) | 2018-12-29 | 2019-12-24 | Bio-coating and implant |
JP2021538400A JP2022516542A (ja) | 2018-12-29 | 2019-12-24 | 生物活性コーティングおよびインプラント |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811642573.9A CN111388156B (zh) | 2018-12-29 | 2018-12-29 | 生物涂层和植入物 |
CN201811642573.9 | 2018-12-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020135423A1 true WO2020135423A1 (zh) | 2020-07-02 |
Family
ID=71126941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2019/127936 WO2020135423A1 (zh) | 2018-12-29 | 2019-12-24 | 生物涂层和植入物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220054716A1 (zh) |
EP (1) | EP3903741B1 (zh) |
JP (1) | JP2022516542A (zh) |
KR (1) | KR20210096653A (zh) |
CN (1) | CN111388156B (zh) |
WO (1) | WO2020135423A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113413253A (zh) * | 2021-07-09 | 2021-09-21 | 上海珥智医疗科技有限公司 | 义鼻 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105233347A (zh) * | 2015-10-30 | 2016-01-13 | 吉林大学 | 一种3d打印梯度孔径医用多孔金属骨组织支架 |
CN204971711U (zh) * | 2015-05-31 | 2016-01-20 | 西安赛隆金属材料有限责任公司 | 一种高强度小孔径金属骨小梁 |
CN205126948U (zh) * | 2015-10-30 | 2016-04-06 | 吉林大学 | 一种3d打印梯度孔径医用多孔金属骨组织支架 |
CN105877874A (zh) * | 2016-04-06 | 2016-08-24 | 四川大学 | 仿生设计类骨多孔骨制品及其制备方法和用途 |
CN107441552A (zh) * | 2017-08-28 | 2017-12-08 | 中国科学院上海硅酸盐研究所 | 一种仿生莲藕结构的生物活性支架及其制备方法和应用 |
WO2018054502A1 (en) * | 2016-09-26 | 2018-03-29 | Siemens Industry Software Nv | Design of lattice structures for additive manufacturing |
CN108992705A (zh) * | 2018-09-28 | 2018-12-14 | 山东建筑大学 | Mg/TiO2-HA梯度多孔涂层的可再生镁基骨骼材料的制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4542539A (en) * | 1982-03-12 | 1985-09-24 | Artech Corp. | Surgical implant having a graded porous coating |
DE60300277T2 (de) * | 2002-11-08 | 2006-01-12 | Howmedica Osteonics Corp. | Lasererzeugte poröse Oberfläche |
ES2546329T3 (es) * | 2003-07-24 | 2015-09-22 | Tecomet Inc. | Espumas no aleatorias ensambladas |
EP1961433A1 (en) * | 2007-02-20 | 2008-08-27 | National University of Ireland Galway | Porous substrates for implantation |
US8383187B2 (en) * | 2009-02-19 | 2013-02-26 | Depuy Products, Inc. | Rough porous constructs |
CN101574541B (zh) * | 2009-06-11 | 2012-12-05 | 同济大学 | 一种高强度肋骨梯度多孔支架的制备方法 |
CA2771384A1 (en) * | 2009-08-19 | 2011-02-24 | Smith & Nephew, Inc. | Porous implant structures |
CN102686250B (zh) * | 2009-11-12 | 2014-09-17 | 史密夫和内修有限公司 | 受控随机化的多孔结构及其制造方法 |
CN103462729B (zh) * | 2012-06-07 | 2016-06-01 | 中南大学 | 一种多级[微米/纳米]孔结构的仿生人工骨的制备方法 |
CN103751852B (zh) * | 2014-01-24 | 2015-06-17 | 天津理工大学 | 一种三维人工随机多孔结构组织工程支架的制备方法 |
CN104887351A (zh) * | 2015-05-31 | 2015-09-09 | 西安赛隆金属材料有限责任公司 | 一种高强度小孔径金属骨小梁及其制备方法 |
EP3606473A4 (en) * | 2017-04-01 | 2020-12-30 | HD Lifesciences LLC | FLUID INTERFACE SYSTEM FOR IMPLANTS |
CN207605043U (zh) * | 2017-06-07 | 2018-07-13 | 中国人民解放军总医院 | 一种用于骨折或骨缺损的骨植入体 |
CN207590799U (zh) * | 2017-06-22 | 2018-07-10 | 宁波创导三维医疗科技有限公司 | 鼻填充物 |
CN107647942A (zh) * | 2017-11-02 | 2018-02-02 | 广州华钛三维材料制造有限公司 | 一种金属骨小梁及包含所述金属骨小梁的骨骼植入物 |
-
2018
- 2018-12-29 CN CN201811642573.9A patent/CN111388156B/zh active Active
-
2019
- 2019-12-24 KR KR1020217020339A patent/KR20210096653A/ko not_active Application Discontinuation
- 2019-12-24 EP EP19905352.1A patent/EP3903741B1/en active Active
- 2019-12-24 US US17/418,155 patent/US20220054716A1/en active Pending
- 2019-12-24 JP JP2021538400A patent/JP2022516542A/ja active Pending
- 2019-12-24 WO PCT/CN2019/127936 patent/WO2020135423A1/zh active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN204971711U (zh) * | 2015-05-31 | 2016-01-20 | 西安赛隆金属材料有限责任公司 | 一种高强度小孔径金属骨小梁 |
CN105233347A (zh) * | 2015-10-30 | 2016-01-13 | 吉林大学 | 一种3d打印梯度孔径医用多孔金属骨组织支架 |
CN205126948U (zh) * | 2015-10-30 | 2016-04-06 | 吉林大学 | 一种3d打印梯度孔径医用多孔金属骨组织支架 |
CN105877874A (zh) * | 2016-04-06 | 2016-08-24 | 四川大学 | 仿生设计类骨多孔骨制品及其制备方法和用途 |
WO2018054502A1 (en) * | 2016-09-26 | 2018-03-29 | Siemens Industry Software Nv | Design of lattice structures for additive manufacturing |
CN107441552A (zh) * | 2017-08-28 | 2017-12-08 | 中国科学院上海硅酸盐研究所 | 一种仿生莲藕结构的生物活性支架及其制备方法和应用 |
CN108992705A (zh) * | 2018-09-28 | 2018-12-14 | 山东建筑大学 | Mg/TiO2-HA梯度多孔涂层的可再生镁基骨骼材料的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
EP3903741B1 (en) | 2023-07-19 |
EP3903741A4 (en) | 2022-03-02 |
EP3903741C0 (en) | 2023-07-19 |
KR20210096653A (ko) | 2021-08-05 |
JP2022516542A (ja) | 2022-02-28 |
CN111388156B (zh) | 2021-09-10 |
EP3903741A1 (en) | 2021-11-03 |
CN111388156A (zh) | 2020-07-10 |
US20220054716A1 (en) | 2022-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN204971711U (zh) | 一种高强度小孔径金属骨小梁 | |
AU2019393104B2 (en) | Bone trabecula structure and prosthesis using same and manufacturing method therefor | |
US20180280140A1 (en) | Anisotropic Biocompatible Lattice Structure | |
JP2020515350A (ja) | インプラント用流体インターフェースシステム | |
CN201631425U (zh) | 生物型组合股骨柄 | |
WO2020135423A1 (zh) | 生物涂层和植入物 | |
CN104055594B (zh) | 具有多孔支架式结构的牙种植体 | |
CN205515049U (zh) | 融合器 | |
CN105903084A (zh) | 一种具有抗菌功能涂层的3d打印多孔支架及其制备方法 | |
CN109758267A (zh) | 一种骨修复用多孔支架及其制备方法 | |
CN109223213A (zh) | 适用于牙种植的多孔结构钛种植体 | |
WO2024131065A1 (zh) | 一种表面多孔的髋臼杯假体分区设计及成型方法 | |
BR112020007004A2 (pt) | dispositivo de eluição de fármaco implantável compreendendo uma estrutura microporosa | |
CN117017577A (zh) | 一种具有完整晶格界面的径向梯度多孔结构、制备方法及应用 | |
CN210056344U (zh) | 一种多孔钽棒 | |
CN110037832A (zh) | 一种骨修复用复合单元结构多孔支架及加工方法 | |
CN111714253A (zh) | 一种基于十四面体的多孔骨诱导结构 | |
CN116807693A (zh) | 一种3d打印晶格结构 | |
CN113231644A (zh) | 一种Ti-6Al-4V合金点阵材料微结构及其设计方法和应用 | |
TWI527558B (zh) | Bone support device | |
CN112168429A (zh) | 一种仿海胆刺形连续梯度变化的生物支架及其应用 | |
CN111603276A (zh) | 一种定制尺骨假体 | |
CN104398327A (zh) | 一种骨骼连接固定用带多孔表面的锁定螺钉 | |
CN114053485B (zh) | 一种用于生物支架的单胞结构及其应用 | |
CN215130921U (zh) | 一种个性化分体式髋臼假体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19905352 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2021538400 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20217020339 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2019905352 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2019905352 Country of ref document: EP Effective date: 20210729 |